Tigermed

Welcome to Tigermed (stock symbol: 300347)We are committed to supporting our clients in their clinical development in the best possible way. As a leading Contract Research Organization (CRO) in China, we are dedicated to enabling our clients to market their products successfully all over the world. Since our inception in 2004, Tigermed has always embraced new technologies and partnerships to accelerate product development and generate the clinical evidence for our clients require to demonstrate real-world value.Headquartered in Hangzhou, Tigermed operates 33 subsidiaries with 95 offices across China and 11 others across the globe employing over 4000 Tigermed colleagues. To his day, we have supported over 600 clients internationally in over 1500 clinical trials. Additionally, we are recognized as “The Innovative Clinical CRO” in China, owning to our meticulous reputation for quality and involvement in the development of over 160 innovative drugs.